Botanical species · safety record

Paeonia officinalis

The EFSA Compendium of Botanicals holds 8 constituent measurements and 1 adverse-effect record for Paeonia officinalis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Paeonia officinalis L.

8Constituent measurements
1Safety records
4Cited sources
70Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 70 licensed products naming Paeonia officinalis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Flower
  • Fresh root(s)
  • Fresh underground parts
  • Fresh underground parts collected during spring
  • Fresh underground parts collected in spring
  • Fresh underground parts in spring
  • Organes souterrains frais au printemps
  • Racine prélevée au printemps

What the records describe

Constituents measured

  • Furan derivatives2
  • Alkaloids1
  • Benzaldehyde1
  • Eugenol1
  • Myrcene1
  • Saponins1
  • Tannins1

Plant parts

  • Roots and other underground parts9

Preparations

  • Essential oil5
  • Solvent extraction4

Effect types

  • Reproductive1

Target tissues

  • Uterus1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsRoots and other underground partsSolvent extractionPhytochemical screeningResolve DOI
SaponinsRoots and other underground partsSolvent extractionPhytochemical screeningResolve DOI
TanninsRoots and other underground partsSolvent extractionPhytochemical screeningResolve DOI
BenzaldehydeRoots and other underground partsEssential oil17.1 PercentGC-MSNo resolvable identifier
EugenolRoots and other underground partsEssential oilGC-MSNo resolvable identifier
Furan derivativesRoots and other underground partsEssential oilGC-MSNo resolvable identifier
Furan derivativesRoots and other underground partsEssential oil2.41 PercentGC-MSNo resolvable identifier
MyrceneRoots and other underground partsEssential oilGC-MSNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
ReproductiveUterusRoots and other underground partsSolvent extractionRat (as animal)Reproduction toxicityNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Li, Xiao-ru., Liang, Yi-zeng., Guo, Fang-qiu. Analysis of volatile oil in Rhizoma Ligustici Chuanxiong-Radix Paeoniae Rubra by gas chromatography-mass spectrometry and chemometric resolution. Acta pharmacologica sinica, 2006, p. 491-498.
  2. Ahmad, Feroz., Tabassum, Nahida. Preliminary phytochemical, acute oral toxicity and antihepatotoxic study of roots of Paeonia officinalis Linn. . Asian pacific journal of tropical biomedicine, 2013, vol. 3, no. 1, p. 64-68. DOI
  3. Li, Xiao-ru., Lan, Zheng-gang., Liang, Yi-zeng. Analysis of volatile chemical components of Radix Paeoniae Rubra by gas chromatography-mass spectrometry and chemometric resolution. Journal of central south university of technology (english edition), 2007, p. 57-61.
  4. Ahmad, F., Tabassum, N., Rasool, S. Medicinal uses and phytoconstituents of Paeonia officinalis. International research journal of pharmacy, 2012, p. 85-87.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue